Merck & Co. has offered to pay $100 million to resolve thousands of NuvaRing lawsuits.
NuvaRing Class Action Lawsuit Information
NuvaRing is an O-shaped birth control device that is inserted directly into the vagina, where it slowly releases hormones to prevent pregnancy. In 2011, the FDA linked these hormones to an increased risk of blood clot-related adverse events, including heart attack, stroke, pulmonary embolism, and death. Although thousands of women were injured, NuvaRing has not been recalled.
In February 2014, Merck & Co. offered to pay $100 million to resolve about 3,800 NuvaRing lawsuits. These lawsuit are not part of a NuvaRing class action. Instead, they are individual lawsuits that have been consolidated in federal court in Missouri. Another 200 women have sued Merck in New Jersey. Click here to read more.
- Blood clot
- Deep vein thrombosis (DVT)
- Pulmonary embolism
- Heart attack
- Venous thromboembolism
- Organ damage
About Class Actions
When a large number of people have a very similar legal claim, class actions make a lot of sense. They are especially useful when drug-makers fail to warn about serious side effects. Instead of everyone filing a lawsuit alone, plaintiffs join together and collectively argue for compensation.
Why Our Law Firm is Filing Individual Lawsuits as Opposed to a NuvaRing Class Action
In many cases, class actions are used to secure a refund for people who purchased defective drugs. However, they are not always ideal for individual plaintiffs with severe injuries. Members of a class action often must accept higher attorneys’ fees or a “low-ball settlement.”